Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's disease,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's disease
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-04-23 , DOI: 10.1111/apt.17968
Agnès Fernández‐Clotet _{1,

2,

3} , Ingrid Ordás _{1,

2,

3} , Maria Carme Masamunt _{1,

2,

3} , Berta Caballol _{1,

2,

3} , Sonia Rodríguez ₄ , Marta Gallego ₁ , Rebeca Barastegui ₁ , Anny Carolina Saavedra ₃ , Julián Panés _{1,

2,

3} , Elena Ricart _{1,

2,

3} , Jordi Rimola _{3,

4}

Affiliation

Magnetic resonance enterography (MRE) depicts transmural changes in response to biological treatment for Crohn's disease (CD); however, the long-term prognostic significance of these findings is unknown. The primary objective of this study was to identify findings on MRE 46 weeks after initiating biological treatment that predict adverse long-term outcomes.

中文翻译：